5%+ stake
5.1%Stake
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Traded Dec 4, 2025 · Filed Dec 5, 2025
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
grant award
Code A — grant or award
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Derivative exercise or conversion — not an open-market buy.
Officer sold ~$264K of Trane Technologies
Scheduled in advance